Your browser is no longer supported. Please, upgrade your browser.
Settings
MYOK MyoKardia, Inc. daily Stock Chart
MYOK [NASD]
MyoKardia, Inc.
Index- P/E- EPS (ttm)-0.67 Insider Own2.20% Shs Outstand37.66M Perf Week13.82%
Market Cap1.63B Forward P/E- EPS next Y-1.80 Insider Trans49.06% Shs Float33.80M Perf Month218.01%
Income-19.40M PEG- EPS next Q-0.42 Inst Own70.30% Short Float2.40% Perf Quarter222.76%
Sales43.40M P/S37.53 EPS this Y54.10% Inst Trans1.39% Short Ratio1.60 Perf Half Y254.51%
Book/sh3.98 P/B10.87 EPS next Y-9.80% ROA-12.20% Target Price49.00 Perf Year118.43%
Cash/sh3.54 P/C12.22 EPS next 5Y- ROE-16.40% 52W Range10.55 - 44.28 Perf YTD233.98%
Dividend- P/FCF102.44 EPS past 5Y- ROI-9.20% 52W High-2.33% Beta-
Dividend %- Quick Ratio4.00 Sales past 5Y- Gross Margin- 52W Low309.95% ATR2.69
Employees78 Current Ratio4.00 Sales Q/Q60.00% Oper. Margin-46.00% RSI (14)82.95 Volatility8.69% 9.70%
OptionableNo Debt/Eq0.00 EPS Q/Q-11.00% Profit Margin-44.70% Rel Volume1.48 Prev Close40.38
ShortableYes LT Debt/Eq0.00 EarningsAug 07 BMO Payout- Avg Volume505.10K Price43.25
Recom1.60 SMA2059.97% SMA50127.65% SMA200190.01% Volume749,150 Change7.12%
Dec-04-15Initiated Wells Fargo Outperform
Nov-23-15Initiated Wedbush Outperform $22
Nov-23-15Initiated Credit Suisse Outperform $18
Aug-16-17 08:58AM  MyoKardia (MYOK) Looks Good: Stock Adds 6.32% in Session Zacks +5.69%
Aug-14-17 11:14AM  MyoKardia Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Aug-10-17 08:00AM  MyoKardia to Present at 2017 Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-09-17 07:30AM  [$$] Zinsli's Take: Biotech's Saviors Keep Up VCs' Hopes The Wall Street Journal
Aug-08-17 08:16PM  MyoKardia Announces Pricing of Public Offering of Common Stock GlobeNewswire +15.10%
04:21PM  Edited Transcript of MYOK earnings conference call or presentation 7-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
04:12PM  MyoKardia Inc. Is on the Rise Again Today -- Here's Why Motley Fool
Aug-07-17 11:59PM  MyoKardia reports 2Q loss Associated Press +83.38%
04:20PM  Why NxStage Medical, MyoKardia, and Rockwell Collins Jumped Today Motley Fool
04:01PM  MyoKardia Announces Proposed Public Offering of Common Stock GlobeNewswire
03:14PM  MyoKardia Shares Almost Double on Latest Clinical Data for Heart Disease Treatment TheStreet.com
12:25PM  Here's Why Myokardia Inc. Stock Shot Up Today Motley Fool
07:34AM  MyoKardia shares surge 32% on positive mid-stage trial results for heart muscle disease MarketWatch
07:19AM  MyoKardia Reports Second Quarter 2017 Financial Results and Operational Progress GlobeNewswire
07:00AM  MyoKardia Reports Positive Topline Results in Phase 2 PIONEER-HCM Study of Mavacamten (Formerly MYK-461) in Symptomatic, Obstructive Hypertrophic Cardiomyopathy GlobeNewswire
Jul-31-17 08:01AM  MyoKardia to Announce Second Quarter 2017 Financial Results and Host Conference Call on Monday, August 7, 2017 GlobeNewswire
Jul-24-17 05:30PM  ETFs with exposure to MyoKardia, Inc. : July 24, 2017 Capital Cube
Jul-21-17 08:37AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : July 21, 2017 Capital Cube
Jul-14-17 03:47PM  ETFs with exposure to MyoKardia, Inc. : July 14, 2017 Capital Cube
Jul-12-17 03:31PM  MyoKardia, Inc. Value Analysis (NASDAQ:MYOK) : July 12, 2017 Capital Cube
Jul-11-17 08:23AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : July 11, 2017 Capital Cube
Jun-28-17 09:01AM  MyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : June 28, 2017 Capital Cube
Jun-15-17 02:42PM  ETFs with exposure to MyoKardia, Inc. : June 15, 2017 Capital Cube
Jun-09-17 09:21AM  MyoKardia, Inc. :MYOK-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017 Capital Cube
Jun-02-17 08:39AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : June 2, 2017 Capital Cube
May-09-17 06:44PM  MyoKardia reports 1Q loss Associated Press
04:02PM  MyoKardia Reports First Quarter 2017 Financial Results and Operational Progress GlobeNewswire
02:15PM  Investor Network: MyoKardia, Inc. to Host Earnings Call Accesswire
May-02-17 08:30AM  MyoKardia to Announce First Quarter 2017 Financial Results and Host Conference Call on Tuesday, May 9, 2017 GlobeNewswire
Apr-26-17 04:21PM  MyoKardia, Inc. Value Analysis (NASDAQ:MYOK) : April 26, 2017 Capital Cube
Apr-25-17 08:58AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : April 25, 2017 Capital Cube
Apr-18-17 08:30AM  MyoKardia Appoints David Meeker, M.D., to Board of Directors GlobeNewswire
Apr-13-17 12:36PM  ETFs with exposure to MyoKardia, Inc. : April 13, 2017 Capital Cube
Apr-06-17 08:27AM  MyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : April 6, 2017 Capital Cube
Mar-23-17 12:13PM  MyoKardia, Inc. :MYOK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 23, 2017 Capital Cube
10:11AM  MyoKardia, Inc. :MYOK-US: Earnings Analysis: 2016 By the Numbers : March 23, 2017
Mar-17-17 01:04PM  MYOKARDIA INC Financials
08:30AM  MyoKardia Appoints Kim Popovits and Wendy Yarno to Board of Directors GlobeNewswire
Mar-13-17 09:11AM  MYOKARDIA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:40AM  MyoKardia reports 4Q loss Associated Press
08:30AM  MyoKardia Reports Fourth Quarter and Full Year 2016 Financial Results and Operational Progress GlobeNewswire
Mar-10-17 07:50AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : March 10, 2017 Capital Cube
Mar-06-17 07:17AM  MYOKARDIA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-02-17 07:00AM  7 Stocks Trending With Monster Volume TheStreet.com
Feb-28-17 08:30AM  MyoKardia to Present at Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Feb-17-17 07:50AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : February 17, 2017 Capital Cube
Feb-02-17 08:30AM  First Subjects Dosed in Phase 1 Study of Dilated Cardiomyopathy Candidate MYK-491 GlobeNewswire
Feb-01-17 05:19PM  MYOKARDIA INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat +6.70%
08:30AM  MyoKardia Announces Appointment of June Lee, M.D., as Chief Operating Officer and Radhika Tripuraneni, M.D., as Vice President, Medical Affairs GlobeNewswire
Jan-03-17 08:41AM  MYOKARDIA INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
08:30AM  MyoKardia Announces Advancement to Next Phase of Global Collaboration with Sanofi GlobeNewswire
Dec-12-16 02:42PM  ETFs with exposure to MyoKardia, Inc. : December 12, 2016
Dec-09-16 03:21AM  Is Myokardia Inc (MYOK) A Good Stock To Buy? at Insider Monkey
Dec-08-16 08:00AM  MyoKardia to Present at 2016 BMO Capital Markets Healthcare Conference GlobeNewswire -5.23%
Dec-05-16 08:15AM  Blog Coverage MyoKardia Announced Receipt of Payment from Sanofi Accesswire
Dec-02-16 08:00AM  MyoKardia Announces Receipt of Milestone Payment from Sanofi for DCM Candidate MYK-491 GlobeNewswire
Dec-01-16 11:42AM  ETFs with exposure to MyoKardia, Inc. : December 1, 2016
08:00AM  MyoKardia Announces Appointment of Marc Semigran, M.D., as Chief Medical Officer GlobeNewswire
07:33AM  MyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : December 1, 2016
Nov-21-16 11:11AM  MyoKardia, Inc. :MYOK-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21, 2016
Nov-15-16 02:01PM  ETFs with exposure to MyoKardia, Inc. : November 15, 2016
Nov-14-16 07:57AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : November 14, 2016
Nov-11-16 08:00AM  MyoKardia Announces Exploratory Digital Health Substudy as Part of PIONEER-HCM Trial of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients GlobeNewswire +7.45%
Nov-07-16 09:01AM  MYOKARDIA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:25AM  MyoKardia reports 3Q loss
08:00AM  MyoKardia Reports Progress on Clinical Programs and Third Quarter 2016 Financial Results GlobeNewswire
Nov-04-16 08:00AM  MyoKardia Announces Presentations at American Heart Association Scientific Sessions 2016 GlobeNewswire +10.34%
Nov-02-16 08:00AM  MyoKardia Announces Dosing of First Patient in Phase 2 PIONEER-HCM Study of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy GlobeNewswire
Oct-31-16 08:00AM  MyoKardia to Present at Two Upcoming Investor Conferences in November GlobeNewswire
Oct-03-16 04:30PM  MyoKardia Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Sep-28-16 03:14PM  Heres Why These Five Stocks Are Trading Higher Today at Insider Monkey +5.95%
Sep-27-16 06:48PM  MyoKardia Announces Pricing of Proposed Public Offering of Common Stock GlobeNewswire
Sep-26-16 04:48PM  MyoKardia Announces Proposed Public Offering of Common Stock GlobeNewswire -6.15%
Sep-22-16 12:00PM  MyoKardia, Inc. Value Analysis (NASDAQ:MYOK) : September 22, 2016
Sep-21-16 08:25AM  MyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : September 21, 2016
07:33AM  MYOKARDIA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
07:00AM  MyoKardia Outlines Path to Registration for MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients and Provides Pipeline and Research Updates at Inaugural R&D Day GlobeNewswire
Sep-14-16 08:45AM  MyoKardia to Host R&D Day on September 21 GlobeNewswire
Sep-12-16 04:27PM  MYOKARDIA INC Files SEC form 8-K, Change in Directors or Principal Officers
Sep-01-16 04:30PM  MyoKardia to Present at 2016 Wells Fargo Healthcare Conference GlobeNewswire
Aug-10-16 08:30AM  MyoKardia to Present at the 2016 Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-09-16 08:52AM  MyoKardia reports 2Q loss
08:38AM  MYOKARDIA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:30AM  MyoKardia Reports Second Quarter 2016 Financial Results and Continued Progress on Clinical Programs GlobeNewswire
Jul-14-16 08:30AM  SHaRe Registry Data Published in PNAS Demonstrate the Power of Combining Clinical, Genetic and Structural Data to Gain Insight into Hypertrophic Cardiomyopathy GlobeNewswire -8.84%
Jul-12-16 01:09PM  Heres What To Look For Ahead Of The Myokardia Inc (MYOK) Phase II at Insider Monkey +31.89%
Jul-11-16 05:00PM  MyoKardia Inc to Discuss Phase 1 Data for MYK-461 Call scheduled for 5:00 pm ET today
04:13PM  MYOKARDIA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:02PM  MyoKardia Announces Topline Clinical Data Supporting Advancement of MYK-461 to Phase 2 PIONEER-HCM Study in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients GlobeNewswire
Jun-28-16 09:16AM  MyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : June 28, 2016
Jun-08-16 04:24PM  MYOKARDIA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-16-16 07:30AM  MyoKardia to Present at 2016 UBS Global Healthcare Conference GlobeNewswire
May-12-16 08:03AM  MYOKARDIA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:43AM  MyoKardia reports 1Q loss
07:30AM  MyoKardia Reports First Quarter 2016 Financial Results and Operational Progress GlobeNewswire
May-02-16 07:30AM  MyoKardia Receives Orphan Drug Designation for MYK-461 for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) GlobeNewswire
Apr-13-16 09:01AM  MYOKARDIA INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat
07:30AM  MyoKardia Names Mary Cranston to Board of Directors GlobeNewswire
Mar-22-16 03:00PM  MyoKardia, Inc. :MYOK-US: Earnings Analysis: 2015 By the Numbers
Mar-18-16 08:32AM  MYOKARDIA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Clinical-stage biotech developing therapies for heritable cardiomyopathies.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lambing JosephSee RemarksAug 15Sale40.005,000200,000104,718Aug 16 04:32 PM
Sanofi10% OwnerAug 14Buy35.50350,00012,425,0004,018,899Aug 16 07:31 AM
YARNO WENDY LDirectorAug 14Buy35.501,40849,9841,408Aug 16 04:33 PM
Lambing JosephSee RemarksAug 08Sale35.005,000175,000109,718Aug 09 05:16 PM
Lambing JosephSee RemarksAug 07Sale27.5010,000275,000114,718Aug 09 05:16 PM
Bauer JakeSee RemarksAug 07Sale28.3315,000425,00065,545Aug 09 05:15 PM
GIANAKAKOS ANASTASIOSPresident and CEOAug 04Option Exercise1.514,3006,479512,463Aug 04 09:31 PM
GIANAKAKOS ANASTASIOSPresident and CEOAug 04Sale16.624,30071,465508,163Aug 04 09:31 PM
GIANAKAKOS ANASTASIOSPresident and CEOJul 25Option Exercise1.5131,85048,094541,151Jul 27 05:11 PM
GIANAKAKOS ANASTASIOSPresident and CEOJul 25Sale15.0032,988494,902508,163Jul 27 05:11 PM
Bauer JakeSee RemarksJul 25Sale15.024,33365,06080,545Jul 27 05:11 PM
GIANAKAKOS ANASTASIOSPresident and CEOMar 20Option Exercise1.511,2001,812509,454Mar 22 08:39 PM
GIANAKAKOS ANASTASIOSPresident and CEOMar 20Sale15.001,41221,180508,042Mar 22 08:39 PM
Bauer JakeSee RemarksMar 20Sale15.0066710,00583,900Mar 22 08:37 PM
Sanofi10% OwnerOct 03Buy15.00450,0006,750,0003,668,899Oct 05 09:00 AM